This inventor holds 1 USPTO granted patent. Top assignee: Obigen Pharma, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Tzu-Wen Tsau: Innovator in Botulinum Toxin Research
Introduction
Tzu-Wen Tsau is a prominent inventor based in Taipei, Taiwan. He is known for his significant contributions to the field of botulinum toxin research. His innovative work has led to advancements in formulations and usage methods that enhance safety and efficacy.
Latest Patents
Tzu-Wen Tsau holds a patent for a "Botulinum toxin type A complex, and formulation thereof and usage method therefor." This invention relates to a botulinum toxin type A complex that includes components such as HA70, HA17, HA33, NINH, and BoNT/A1. The complex has a molecular weight of 740-790 kDa, which is smaller than existing botulinum toxin complexes. This innovation offers higher safety and comparable treatment effects.
Career Highlights
Tzu-Wen Tsau is associated with Obigen Pharma, Inc., where he continues to develop groundbreaking solutions in the field of botulinum toxin. His work is characterized by a commitment to improving patient safety and treatment outcomes.
Collaborations
Tzu-Wen Tsau collaborates with notable colleagues, including Yung-Kai Wang and Kuan-Cheng Shen. Their combined expertise contributes to the advancement of research and development in their field.
Conclusion
Tzu-Wen Tsau's innovative contributions to botulinum toxin research exemplify his dedication to enhancing medical treatments. His work not only advances scientific knowledge but also prioritizes patient safety and efficacy in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile